Effect of COVID-19 on Liver Enzymes in Hospitalized COVID-19 Patients in the Gaza Strip: A Retrospective Study
DOI:
https://doi.org/10.35516/jjps.v16i2.1329Keywords:
COVID-19, SARS-CoV-2, Liver enzymes, Liver damageAbstract
In severe cases, the novel coronavirus disease 2019 (COVID-19) can cause respiratory failure and multiple organ dysfunction, including liver injury. This study assessed the COVID-19 effect on liver function among hospitalized COVID-19 patients. Three-hundred and seventy patients were recruited. Patients were distributed as the following: control group (n=100), intensive care unit (ICU) hospitalized COVID-19 patients (n=140), and non-ICU hospitalized COVID-19 group (n=130). Data about the levels of liver enzymes were collected from the hospital medical records of the participants. Our results showed a significant increase in alanine aminotransferase (ALT) levels among the ICU hospitalized COVID-19 patients compared with the non-ICU hospitalized COVID-19 patients (p-value <0.01) and the controls (p-value <0.001). Aspartate aminotransferase (AST) concentration significantly increased among the ICU-hospitalized COVID-19 group compared with the non-ICU hospitalized COVID-19 group (p-value <0.01) and the controls (p-value <0.05). The ICU-hospitalized COVID-19 patients had a higher increase in alkaline phosphatase (ALP) levels compared to the non-ICU hospitalized COVID-19 patients and controls (p values <0.001). Based on ALT, AST, and ALP levels, we found that 73 (52%), 77 (55%), and 38 (27%) of the ICU hospitalized COVID-19 patients developed a liver injury. Of those, 12 (8.5%) died compared to 5 (3.5%) patients with abnormal liver function. In conclusion, these findings suggest that COVID-19 disease is associated with abnormal liver function and liver injury.
References
Guan W., Ni Z., Hu Y., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020.
Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.
Lu H., Stratton CW., Tang Y-W. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J. Med. Virol. 2020;92(4):401–402.
Zhu N., Zhang D., Wang W., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382(8):727–733.
Zhou P., Yang XL., Wang XG., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273.
Ren LL., Wang YM., Wu ZQ., et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin. Med. J. (Engl.). 2020
Gorbalenya AE., Baker SC., Baric RS., et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv. 2020;2020.02.07.937862.
WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020.
WHO Coronavirus (COVID-19) Dashboard.
Letko M., Marzi A., Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 2020;5(4):562–569.
Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet Lond. Engl. 2020;395(10223):507–513.
Wang D., Hu B., Hu C., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
Al Jomaa EE., Al Meslamani A., Abazid H. A Comparative Cross-Sectional Study- Knowledge, behavior and psychological change among Medical and Non-medical Students in Jordan during COVID-19 pandemic. Jordan J. Pharm. Sci. 2022;15(2):204–213.
Cai Q., Huang D., Yu H., et al. COVID-19: Abnormal liver function tests. J. Hepatol. 2020;73(3):566–574.
Tay MZ., Poh CM., Rénia L., MacAry PA., Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 2020;20(6):363–374.
Borra SS., C K N., Kumar D., M A., G K S. A Comprehensive Review on Efficacy and Adverse Events Associated With Different Covid-19 Vaccines. Jordan J. Pharm. Sci. 2022;15(2):289–304.
Yang W., Cao Q., Qin L., et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. J. Infect. 2020;80(4):388–393.
Xu Z., Shi L., Wang Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8(4):420–422.
Sharma P., Kumar A., Anikhindi S., et al. Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know? J. Clin. Exp. Hepatol. 2021;11(4):484–493.
Chai X., Hu L., Zhang Y., et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. 2020.
Marjot T., Webb GJ., Barritt AS., et al. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat. Rev. Gastroenterol. Hepatol. 2021;18(5):348–364.
Wang Y., Liu S., Liu H., et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J. Hepatol. 2020;73(4):807–816.
Elmunzer BJ., Spitzer RL., Foster LD., et al. Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019. Clin. Gastroenterol. Hepatol. 2021;19(7):1355-1365.e4.
Hundt MA., Deng Y., Ciarleglio MM., Nathanson MH., Lim JK. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology. 2020;72(4):1169–1176.
Youssef M., H Hussein M., Attia AS., et al. COVID-19 and liver dysfunction: A systematic review and meta-analysis of retrospective studies. J. Med. Virol. 2020;92(10):1825–1833.
Hajifathalian K., Krisko T., Mehta A., et al. Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications. Gastroenterology. 2020;159(3):1137-1140.e2.
Jin X., Lian JS., Hu JH., et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002–1009.
Lin L., Jiang X., Zhang Z., et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020;69(6):997–1001.
Shu L., Wang X., Li M., et al. Clinical Characteristics of 545 Cases Confirmed COVID-19 in Wuhan Stadium Cabin Hospital. Rochester, NY: Social Science Research Network; 2020.
Yao N., Wang SN., Lian JQ., et al. Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region. Zhonghua Gan Zang Bing Za Zhi Zhonghua Ganzangbing Zazhi Chin. J. Hepatol. 2020;28(3):234–239.
Zhao Z., Xie J., Yin M., et al. Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei, China. 2020.
Sultan S., Altayar O., Siddique SM., et al. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020;159(1):320-334.e27.
Cholankeril G., Podboy A., Aivaliotis VI., et al. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California. Gastroenterology. 2020;159(2):775–777.
Fan Z., Chen L., Li J., et al. Clinical Features of COVID-19-Related Liver Functional Abnormality. Clin. Gastroenterol. Hepatol. 2020;18(7):1561–1566.
Liao X., Li D., Ma Z., et al. 12-Month Post-Discharge Liver Function Test Abnormalities Among Patients With COVID-19: A Single-Center Prospective Cohort Study. Front. Cell. Infect. Microbiol. 2022;12.
Zhu X., Wang J., Du J., et al. Changes in Serum Liver Function for Patients with COVID-19: A 1-Year Follow-Up Study. Infect. Drug Resist. 2022; 15:1857–1870.
